Erythroblasts are precursor cells in the process of erythropoiesis, which is the formation of red blood cells (erythrocytes). These cells are derived from hematopoietic stem cells in the bone marrow and undergo a series of differentiation stages before maturing into fully functional red blood cells. Erythroblasts are characterized by their distinct morphology, with a nucleus that gradually decreases in size as the cell matures. During erythropoiesis, erythroblasts actively synthesize hemoglobin, the oxygen-carrying pigment found in red blood cells. The gradual reduction in cell size and loss of the nucleus are essential steps in preparing the erythroblast for its role in oxygen transport. The final stages of erythropoiesis involve the shedding of the nucleus, resulting in a biconcave disc-shaped mature red blood cell. Erythroblasts respond to signals such as erythropoietin, a hormone that stimulates red blood cell production in response to low oxygen levels. Conditions affecting erythropoiesis or hemoglobin synthesis can lead to anemia. Understanding the stages of erythropoiesis, including the role of erythroblasts, is crucial for unraveling the mechanisms of blood cell development and addressing disorders related to red blood cell production. Ongoing research continues to explore the molecular pathways and regulatory factors involved in erythroblast differentiation and maturation.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy